CCEL Stock Analysis: Buy, Sell, or Hold?
CCEL - Cryo-Cell International Inc.
$3.50
0.00 (0.00%)
▲
5d:
-1.96%
30d:
-3.62%
90d:
+0.86%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Jul 21, 2026
6d
Get Alerted When CCEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CCEL shows positive signals but monitor for confirmation. Market pricing in 0.4% decline. Moderate conviction.
💡 BUY OPPORTUNITY: CCEL shows positive signals but monitor for confirmation. Market pricing in 0.4% decline. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CCEL is currently trading at $3.50, which is considered fair relative to its 30-day fair value range of $3.30 to $3.78. The stock's valuation (Forward PE: 175.0) is in line with its historical norms (177.0). Remarkably, the market is currently pricing in an annual earnings decline of 0.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CCEL is in a uptrend. Immediate support is located at $3.14, while resistance sits at $3.80.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.50 (+142.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CCEL is in a uptrend. Immediate support is located at $3.14, while resistance sits at $3.80.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.50 (+142.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.30 -
$3.78
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 142.9% below Wall St target ($8.50)
Trading Range Analysis
30-Day Trading Range
$3.30 -
$3.78
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.14
Resistance Level
$3.80
Current Trend
Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
175.00
Wall Street Target
$8.50
(+142.9%)
Revenue Growth (YoY)
-3.6%
Earnings Growth (YoY)
-80.5%
Profit Margin
-8.5%
Valuation Discount vs History
-0.4% cheaper
PE vs Historical
175.0 vs 177.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.4%
(market-implied from PE analysis)
1-Year Target
$3.49
(0%)
2-Year Target
$3.47
(-1%)
3-Year Target
$3.46
(-1%)
3-Yr Target (if PE normalizes)
(PE: 175→177)
$3.50
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 175.0, Growth: -81.8%)
$2.55
(+-27%)
Base:
(SPY PE: 21.8, Growth: -81.8%)
$0.32
(-91%)
Bear:
(PE: 18.5, Growth: -81.8%)
$0.27
(-92%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 175.0 to 177.0
Stabilization Target:
$3.54
(+1.1%)
PE Expansion Potential:
+1.1%
Share & Embed Analysis
Last updated: July 14, 2026 1:12 PM ET
Data refreshes hourly during market hours. Next update: 2:12 PM
Data refreshes hourly during market hours. Next update: 2:12 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CCEL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$244 | 62 BUY |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$494 | 61 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 58 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 53 HOLD |
|
OPCH
Option Care Health Inc |
STRONG BUY
10 analysts |
$29 | 64 BUY |
